Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Immunology
|
May 1, 1996
Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG
F Silvestris, O D'Amore, P Cafforio, et al.
The Journal of Experimental Medicine
|
December 1, 1996
Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients
F Silvestris, S Nagata, P Cafforio, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 6, 2000
Immunogenicity of an eight amino acid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis
F Silvestris, T Cocco, P Cafforio, et al.
Lupus
|
February 18, 2003
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus
F Silvestris, D Grinello, M Tucci, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 6, 2000
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease
F Silvestris, P Cafforio, M Tucci, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity
M A Frassanito, F Silvestris, P Cafforio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 23, 2016
Extracorporeal shock waves induce osteogenic differentiation of human bone-marrow stromal cells
A Notarnicola, G Vicenti, G Maccagnano, et al.
International Journal of Clinical & Laboratory Research
|
January 8, 1999
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia
F Silvestris, P Cafforio, G Camarda, et al.
AIDS Research and Human Retroviruses
|
May 26, 2001
Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection
F Silvestris, D Grinello, A Del Prete, et al.
Clinical and Experimental Medicine
|
June 7, 2002
Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease
F Silvestris, R C Williams, N Calvani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Immunology
|
May 1, 1996
Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG
F Silvestris, O D'Amore, P Cafforio, et al.
The Journal of Experimental Medicine
|
December 1, 1996
Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients
F Silvestris, S Nagata, P Cafforio, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 6, 2000
Immunogenicity of an eight amino acid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis
F Silvestris, T Cocco, P Cafforio, et al.
Lupus
|
February 18, 2003
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus
F Silvestris, D Grinello, M Tucci, et al.
Molecular Medicine (Cambridge, Mass.)
|
September 6, 2000
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease
F Silvestris, P Cafforio, M Tucci, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1997
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity
M A Frassanito, F Silvestris, P Cafforio, et al.
Journal of Biological Regulators and Homeostatic Agents
|
December 23, 2016
Extracorporeal shock waves induce osteogenic differentiation of human bone-marrow stromal cells
A Notarnicola, G Vicenti, G Maccagnano, et al.
International Journal of Clinical & Laboratory Research
|
January 8, 1999
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia
F Silvestris, P Cafforio, G Camarda, et al.
AIDS Research and Human Retroviruses
|
May 26, 2001
Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection
F Silvestris, D Grinello, A Del Prete, et al.
Clinical and Experimental Medicine
|
June 7, 2002
Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease
F Silvestris, R C Williams, N Calvani, et al.
Page
of 3